Here are seven things to know about the company’s Q1 results:
1. Surgalign’s first quarter revenue reached $16.7 million, as compared with $20.6 million in the first quarter of last year and $20.6 million last quarter.
2. The revenue decrease was due in part to a reduction in product offerings related to ongoing restructuring efforts.
3. The company saw a gross margin of 63.7 percent, down 520 basis points from a year ago.
4. Operating expenses were up $1.3 million to $24.4 million for the quarter.
5. The company saw an operating loss of $1.1 million, compared with $8.9 million a year ago.
6. Adjusted earnings saw a loss of $10.8 million.
7. During the quarter Surgalign’s Holo artificial intelligence spine imaging tool expanded into two new sites and one new state.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
